Related Experiment Videos
Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?
K Ray Chaudhuri1,2, Peter Jenner3, Angelo Antonini4
1King's College London, Department of Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apathy in Lewy Body Disorders: A Position Paper.
Movement disorders : official journal of the Movement Disorder Society·2026
Where does excessive beta in Parkinson's disease originate? Insights from a case of unilateral cortico-pallidal pathway dysfunction.
Journal of Parkinson's disease·2026
Population pharmacokinetic analyses comparing immediate-release levodopa/carbidopa, controlled-release levodopa/carbidopa, and IPX203. Findings from a phase 1 study in healthy volunteers.
Journal of neural transmission (Vienna, Austria : 1996)·2026
Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive Function.
Movement disorders : official journal of the Movement Disorder Society·2026
Challenges of Pain in Parkinson's Disease: Results from the OCEAN Study.
Movement disorders : official journal of the Movement Disorder Society·2026
Longitudinal Iron Changes in the Substantia Nigra of Early-Stage Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society·2026
Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.
Movement disorders : official journal of the Movement Disorder Society·2026
Distinct Spatiotemporal Patterns of Dopaminergic and Metabolic Imaging in De Novo Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society·2026
Fifteen-Year Outcomes of Bilateral Pallidal Stimulation in Isolated Generalized Dystonia: Characterization of Therapeutic Response and Emergence of Parkinsonism.
Movement disorders : official journal of the Movement Disorder Society·2026
Dopamine-Deficiency-Related Reorganization of the Somatomotor Network in Prodromal and Early Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society·2026
The Effect of LRRK2 and GBA1 Mutations on Survival in Early- and Late-Onset Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society·2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026
Pharmacogenomic and Medicinal Chemistry Perspectives on Off-label Drug Use.
Mini reviews in medicinal chemistry·2026
A SHAP-Informed Formal Feature Attribution Framework for Drug-Drug Interaction Risk in Large-Scale Claims Data.
Clinical and translational science·2026
Qualitative evidence of service user experiences and perspectives on long-acting injectable buprenorphine for opioid treatment - a scoping review.
The International journal on drug policy·2026
US postmarketed drug removals: Analysis of discontinued and withdrawn drugs.
The Journal of pharmacology and experimental therapeutics·2026
Examining Increased Ritalin and Adderall Use Among Low-Income People Who Use Drugs: Mixed Methods Study.
JMIR formative research·2026